Rankings
▼
Calendar
ORKA
Oruka Therapeutics, Inc.
$1B
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$7,000
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-83.24
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$17M
Total Liabilities
$3M
Stockholders' Equity
$14M
Cash & Equivalents
$8M
← FY 2017
All Quarters
Q4 2017 →
ORKA Q3 2017 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena